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Previously we showed that adding fibrillar (f)Aβ25–35, a proxy retaining the main 
physical and biological features of Aβ42, stimulated untransformed astrocytes iso-
lated from fragments of the adult human temporal lobe cerebral cortex to synthesize 
and accumulate large amounts of endogenous Aβ42 and its oligomers, while releas-
ing excess amounts of nitric oxide (NO) and of vascular endothelial growth factor 
(VEGF-A) [1,2]. Here, we investigated the effects of fAβ25-35 and soluble (s)Aβ25-35 
on Aβ42 and Aβ40 accumulation/secretion by human cortical astrocytes and HCN-
1A neurons. And since the calcium-sensing receptor (CaSR) binds Aβs, we studied 
whether calcium-CaSR signaling plays any role in such Aβ25-35-elicited effects and 
their modulation by NPS 2143, a CaSR allosteric antagonist (calcilytic). The fAβ25-
35-exposed astrocytes and neurons produced, accumulated, and secreted increased 
amounts of Aβ42, while Aβ40 also accrued but its secretion was unchanged. Accord-
ingly, secreted Aβ42/Aβ40 ratio values rose for astrocytes and neurons but NPS 2143 
addition specifically suppressed the fAβ25-35-elicited surges of endogenous Aβ42 
secretion by both cell types. Therefore, NPS 2143 addition always kept Aβ42/Aβ40 
values to baseline or lower levels. Compared to fAβ25-35, sAβ25-35 also stimulated Aβ42 
secretion by astrocytes and neurons and NPS 2143 specifically and wholly suppressed 
this effect. Therefore, since NPS 2143 prevents any Aβ/CaSR-induced surplus secre-
tion of endogenous Aβ42 and hence further vicious cycles of Aβ self-induction/secre-
tion/spreading, the CaSR antagonists like NPS 2143 might be novel therapeutic drugs 
for Alzheimer’s disease.
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